Precision Over Promise: Prof. Mike Chan Brings the Science of Targeted Regeneration to Jamaica

KINGSTON, Jamaica (Jan 31-Feb 1, 2026) — In a city better known globally for music and maritime trade, a different kind of conversation took center stage this weekend. It’s about how humans age, why organs fail, and whether decline is inevitable.

At the New Age Regenerative Medicine Conference held from January 31 to February 1 at the Jamaica Conference Center, Prof. Dato’ Sri Dr. Mike Chan delivered two keynote lectures that challenged conventional thinking on stem cells, longevity and disease management, urging doctors to abandon generic approaches in favor of biological precision.

“Regenerative medicine only works when it is specific,” Prof. Mike Chan told delegates.

“You cannot inject one solution and expect it to repair everything. The brain is not muscle. The pancreas is not the liver. If you want results, you must respect biology.”

From Lifespan to Healthspan

Chan’s opening keynote focused on neurodegenerative diseases and aging, drawing a clear line between living longer and living well.

“Longevity without function is meaningless,” he said. “If a person lives to 90 but loses mobility, memory and independence at 70, that is not success. That is prolonged decline.”

In his lecture, titled “Precision in Regenerative Medicine Through Targeted Organ and Brain (Alzheimer’s & Dementia)-Specific Stem Cell, Peptides & Exosomes in Health Span to Lifespan,” Chan explained that diseases such as Alzheimer’s and dementia require organ- and region-specific biological support.

“Alzheimer’s is not a single disease,” he said. “Different brain regions deteriorate at different rates. If you do not target the correct areas with the correct biological signals, you are only guessing — and medicine should never guess.”

He warned that much of what is marketed globally as regenerative medicine lacks scientific rigor. “Hype damages this field,” Chan said. “Patients suffer when science is replaced by slogans. Precision is not optional — it is ethical responsibility.”

Why Animals Matter in Human Longevity

Chan returned to the stage on Sunday (Feb 1) to address an often-overlooked area of regenerative science: veterinary and comparative immunology.

His second keynote, “Stem Cell Peptides and Immunology for Animals in Regenerative and Longevity Medicine,” explored how animal biology offers critical insights into immune regulation and tissue repair.

“Animals teach us what balance looks like,” he said. “Their immune systems respond faster, cleaner and often more predictably. When we understand those mechanisms, we improve safety and effectiveness in human therapies.”

He added that regenerative medicine must be tested and refined through evidence, not assumption.

“Nature does not lie,” Chan said. “If a therapy does not work across biological systems, it will eventually fail in humans too.”

Debate, Dialogue and the Human Element

Chan later joined a panel discussion with Dr. Ian White and Dr. Jonathan Lakey, examining regulatory standards, patient safety and the future direction of regenerative medicine.

Away from the microphones, the conference was marked by informal exchanges among peers. In private messages shared during the event, colleagues praised Chan’s clarity and depth.

One doctor wrote: “Your talk today was fantastic — no real changes to suggest.”

Another added: “It was really good, Dr. Chan. You had my attention the entire time.”

Chan responded briefly from Jamaica, acknowledging the feedback as the sessions concluded.

Why Jamaica, Why Now

The growing interest in regenerative medicine in Jamaica reflects broader national pressures. Like many Caribbean nations, Jamaica faces a heavy burden of chronic diseases — including diabetes, cardiovascular illness and mobility-related conditions — alongside a steadily aging population.

Kingston, the island’s capital and economic hub, has increasingly positioned itself as a regional meeting point for medical dialogue and professional education. While Jamaica’s healthcare system provides broad access through public hospitals and clinics, long-term disease management remains a challenge.

Against this backdrop, conferences such as this one signal a search for solutions that go beyond symptom control.

“Every country is asking the same questions,” Chan said in closing.

“How do we reduce long-term suffering? How do we keep people functional? And how do we apply science responsibly, without false hope?”

Testimonials: Collegial Recognition

While the formal sessions at the Jamaica Conference Center focused on science, regulation and clinical frameworks, the true measure of impact was reflected in the responses from fellow physicians.

Following his keynote addresses, Prof. Dato’ Sri Dr. Mike Chan received immediate messages of professional commendation from attending clinicians across Jamaica, the Bahamas and North America.

Dr. Greg Buckley shared:

“We were just discussing how great it was to speak with you. Thank you for your time. Your talk today was fantastic — there were really no changes to suggest.”

Dr. André Jamaica. noted:

“It was really good, Dr. Chan. You had my attention the entire time.”

Dr. Marcus Lee reflected:

“Very interesting. It was exciting to see the possibilities in functional and regenerative medicine.”

Senior medical figures including Prof. Dr. Danny Johnson of the Bahamas and Prof. Dr. Jonathan Lakey of the University of California also participated in the discussions, reinforcing the international scope and academic caliber of the event.

In a discipline frequently clouded by overstatement, the tone of peer feedback in Kingston was measured yet emphatic — affirming both the scientific rigor and clarity of Prof. Chan’s presentations.

A Global Conversation, Caribbean Setting

The New Age Regenerative Medicine conference was organized by ScDLEAP Jamaica, a professional education platform that has steadily built the meeting into a regional forum linking Caribbean practitioners with international experts.

European Wellness Biomedical Group, founded by Chan, participated as an exhibitor, showcasing several of its biomedical and longevity-focused brands, including EW, MF3, MF+, FCTI and LAB RMS.

As the conference closed, Prof. Mike Chan left delegates with a message that echoed through both days of discussion.

“Regeneration is not about miracles,” he said. “It is about understanding decline early, targeting it correctly, and giving the body what it needs to repair itself. That is not the medicine of the future. That is the medicine we need now.”